Revive Therapeutics Ltd (RVVTF)

[RioDad]

Just to set realistic expectations here about the P3 trial of Bucillamine.

As soon as the first recruitment happens, the trial must start within 72 hours.

Recruiting of subjects could be limited, causing a slow rolling accumulation of participants.

Doctors have to identify a subject that is within their first day of positive test OR symptoms, that way they can recruit them into the trial. Keep in mind, many Subjects approached will say “No”, due to all the paperwork, follow up, and participation required for a study.

Then for those that say YES, get paperwork filled out (In time), start the medication (In time), logistics of follow up, blood work, etc.

72 hours ( 3 days ) is a tough timeline, because many people don’t even alert a doctor of symptoms within that time frame.

Now this isn’t meant to scare any of you investors, as recruiting will be a rolling total and not all on the same start date like many Pharma trials.

I doubt that RVVTF does a large PR notice that they’ve got a few people recruited. I would expect notice that they’ve got 250-ish subjects who have finished or currently on medication within the P3 Trial perimeters.

At that point you’ll probably get some indication of how the trial is going within 1-3 weeks.
If results are good, they’ll continue with the trials, and give preliminary data, and get to the goal of 1000.
If results are bad, trial discontinued most likely.

These are educated guesstimates on my part.